VETOQUINOL Corporate brochure 2007 (year 2006)

APRIL 2006 South Korea Our distributor in South Korea, Semyung Vet, has become Vétoquinol’s 16 th commercial subsidiary. This company has been the exclusive distributor of Vétoquinol products for 15 years. MAI 2006 Expanding product range Launch of Marbocyl ® S, a new addition to the Marbocyl ® range for livestock. A single-injection antibiotic for treating respiratory infections in cattle, Marbocyl ® S is quick-acting, thus avoiding any risk of contagion. This innovation is the result of a new method of development used by the R&D teams at Vétoquinol. SEPTEMBER 2006 New anthelmintic Launch of Dolpac ® , a new broad spectrum, single-dose anthelmintic for treating the main types of worm affecting dogs. At the same time, Vétoquinol raises owners’ awareness about worming more often. The treatment recom- mendations emphasize how a dog may conta- minate the people around it. This is a way of reducing the number of cases of zoonosis every year caused by companion animals. AN EVENTFUL YEAR NOVEMBER 2006 Stock market Vétoquinol shares were listed on 17 November 2006 on the Eurolist of Euronext™ Paris – Compartment B. 1,799,128 shares representing about 16% of the capital were floated on the market. The quoted price was 21 euros at start of trade. 80,827 shares were set aside for salaried staff at Vétoquinol SA (Fonds Commun de Placement) : 75% of salaried staff subscribed, a sign of their faith in the company. OCTOBER 2006 NENUphar Inauguration of the “NENUphar” project. Vétoquinol has invested 15 million euros in its main manufacturing site at Lure in Haute-Saône, France. The three new buildings measuring 7,500 m 2 are occupied by the departments for quality control, packaging of sterile liquid medicinal products and logistics.